Clinical and Biochemical Consequences of CYP17A1 Inhibition with Abiraterone Given with and without Exogenous Glucocorticoids in Castrate Men with Advanced Prostate Cancer.

G Attard, AH Reid, RJ Auchus, Beverly Hughes, AM Cassidy, E Thompson, NB Oommen, E Folkerd, M Dowsett, Wiebke Arlt, JS de Bono

    Research output: Contribution to journalArticle

    177 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Clinical and Biochemical Consequences of CYP17A1 Inhibition with Abiraterone Given with and without Exogenous Glucocorticoids in Castrate Men with Advanced Prostate Cancer.'. Together they form a unique fingerprint.

    Medicine & Life Sciences

    Chemistry